Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

NeuroDerm

Biotech & Life Sciences · Rehovot, Israel · Founded 2003 · IPO 2014 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.10B
Market cap · 2026

Investors

2 investors on NeuroDerm's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Robert Taub
Series B+ 1 investor entered at this stage
The Elias Group

Global footprint

Where NeuroDerm has talent and traffic

Web traffic by country
700 monthly visits
across markets
🇬🇧 United Kingdom85.7%
🇮🇳 India14.3%
🇮🇱 Israel0%
Top 3 markets shown

Patent intelligence

$46M patent portfolio · 28 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$46M
4.2% of market cap · 2.3× smaller than top peer COMPASS Pathways ($106M)
28 active patent families
Where NeuroDerm innovates CarbidopaDOPA Decarboxylase InhibitorsPharmaceutical drugDepressantDopamine
Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

NeuroDerm on the five Patsnap quality dimensions

NeuroDerm in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where NeuroDerm concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across NeuroDerm and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See NeuroDerm on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo